Trial intelligence / Profile preview

Intranasal Dexmedetomidine Premedication in Children Undergoing Adenotonsillectomy With Recent Mild URI

NCT05639777Phase 4Unknown

Sponsor
Tanta University
Start
Dec 2022
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in perioperative pulmonary complications (PPCs) (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of peri-operative respiratory adverse effects. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

perioperative pulmonary complications (PPCs)

Beyond the preview

Go deeper on NCT05639777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05639777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call